Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
申请人:Hormann Eugene Robert
公开号:US20050209283A1
公开(公告)日:2005-09-22
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES IN MAMMALIAN SYSTEMS VIA AN ECDYSONE RECEPTOR COMPLEX
申请人:Hormann Robert Eugene
公开号:US20080194521A1
公开(公告)日:2008-08-14
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes in Mammalian Systems via an Ecdysone Receptor Complex
申请人:Intrexon Corporation
公开号:US20150005256A1
公开(公告)日:2015-01-01
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
The Cl2(PCy3)(IMes)Ru(CHPh) catalyst: olefin metathesis versus olefin isomerization
作者:Damien Bourgeois、Ange Pancrazi、Steven P Nolan、Joëlle Prunet
DOI:10.1016/s0022-328x(01)01269-4
日期:2002.2
While investigating RCM of substrates requiring elevated temperatures and extended reaction times, significant isomerization of one of the double bonds in the starting diene was observed with the recently developed [RuIMes] catalyst. This isomerization appeared as an important drawback of the catalyst, but a judicious selection of solvent and additive can completely eliminate this side reaction. (C) 2002 Elsevier Science B.V. All rights reserved.